Fangda special steel: no transferee delisted at the expiration of the listing period of 60% equity transfer of jiangte automobile

Chassis Supply Chain's "iPhone Moment": China's Tier 1 Shift as LeeKr Emerges

Over the past decade, China's electric vehicle (EV) industry has evolved from a niche experiment into a leading force in the global automotive landscape. In the first ten months of 2025, China exported over 2 million EVs, nearly double the year-earlier figure. From European city streets to Southeast Asian highways and Latin American urban centers, Chinese EVs have emerged as one of the most prominent symbols of a new era of “Made in China.”

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Mabwell Signs GCC Licensing Deal with Saudi Arabia’s SVAX for Aflibercept Biosimilar

Mabwell (Shanghai) Bioscience Co., Ltd.（迈威（上海）生物科技股份有限公司）has entered into a licensing agreement with Saudi Arabian biopharmaceutical company SVAX Inc. covering its aflibercept biosimilar, 9MW0813, in the Gulf Cooperation Council market.

CFMOTO’s Overseas Revenue More Than Quintuples in Five Years, Reaching 70% of 2025 Sales

Zhejiang CFMOTO Power Co., Ltd.（浙江春风动力股份有限公司）, the Hangzhou-based powersports manufacturer behind the CFMOTO brand, generated CNY 13.79 billion in overseas revenue in 2025, accounting for 69.8% of its total sales. The figure was up 27.6% from a year earlier and more than five times the CNY 2.555 billion the company recorded in overseas sales in 2020.

Topchoice Medical: Is One Hospital Chain Propping Up this Rising Listed Company?

Behind the buoyant share prices of a unique healthcare offering in China.subsidiaries’ statements has contributed a large part.